Overlap Syndrome of Antisynthetase Syndrome and Rheumatoid Arthritis: A Case Report |
Jang, Hui-Won
(Department of Internal Medicine, Yonsei University College of Medicine)
Ha, You-Jung (Department of Internal Medicine, Yonsei University College of Medicine) Kang, Yoon (Department of Internal Medicine, Yonsei University College of Medicine) Lee, Kwang-Hoon (Department of Internal Medicine, Yonsei University College of Medicine) Park, Yong-Beom (Department of Internal Medicine, Yonsei University College of Medicine) Lee, Soo-Kon (Department of Internal Medicine, Yonsei University College of Medicine) |
1 | Marguerie C, Bunn CC, Beynon HL, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-1038. DOI |
2 | Oddis CV, Medsger TA Jr, Cooperstein LA. A subluxing arthropathy associated with the anti-Jo-1 antibody in polymyositis/ dermatomyositis. Arthritis Rheum 1990;33:1640-1645. DOI ScienceOn |
3 | Imbert-Masseau A, Hamidou M, Agard C, Grolleau JY, Cherin P. Antisynthetase syndrome. Joint Bone Spine 2003;70:161-168. DOI ScienceOn |
4 | Wasicek CA, Reichlin M, Montes M, Raghu G. Polymyositis and interstitial lung disease in a patient with anti-Jo1 prototype. Am J Med 1984;76:538-544. DOI ScienceOn |
5 | Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980;23:881-888. DOI ScienceOn |
6 | Venables PJ. Polymyositis-associated overlap syndromes. Br J Rheumatol 1996;35:305-306. DOI |
7 | Bohan A, Peter JB. Polymyositis and dermatomyositis (first of two parts). N Engl J Med 1975;292:344-347. DOI ScienceOn |
8 | Meyer O, Charlanne H, Cherin P, et al. Subluxing arthropathy: an unusual manifestation of the antisynthetase syndrome. Ann Rheum Dis 2009;68:152-153. |
9 | Nagashima T, Sato H, Minota S. Destructive arthropathy associated with dermatomyositis sine myositis positive for anti-Jo-1 and anti-cyclic citrullinated peptide antibodies. J Rheumatol 2009; 36:2133-2134. DOI ScienceOn |
10 | Matsui T, Shimada K, Ozawa N, et al. Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritis. J Rheumatol 2006;33:2390-2397. |
11 | Bell DA. Can we rely on anti-citrulline antibody determination for the diagnosis of early rheumatoid arthritis? J Rheumatol 2006; 33:2369-2371. |
12 | Narvaez JA, Narvaez J, De Lama E, De Albert M. MR imaging of early rheumatoid arthritis. Radiographics 2010;30:143-163. DOI ScienceOn |
13 | O'Neill TW, Maddison PJ. Rheumatoid arthritis associated with myositis and anti-Jo-1 antibody. J Rheumatol 1993;20:141-143. |
14 | Ponyi A, Constantin T, Danko K. Antiphospholipid and antisynthetase syndrome in a patient with polymyositis-rheumatoid arthritis overlap. Clin Rheumatol 2004;23:371-372. |
15 | Park CK, Kim TJ, Cho YN, et al. Development of antisynthetase syndrome in a patient with rheumatoid arthritis. Rheumatol Int 2011;31:529-532. DOI ScienceOn |
16 | Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/ European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-2581. DOI ScienceOn |
17 | Boers M, Verhoeven AC, Markusse HM, et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997;350:309-318. DOI ScienceOn |